Loading
Imagion Biosystems
Imagion Biosystems makes an MRI contrast agent of tiny magnetic particles that stick to a cancer marker, so a scan can show whether HER2-positive breast cancer has spread to the lymph nodes without a biopsy.
Also called: Imagion Biosystems, Ltd.Imagion Biosystems, Inc.
Overview
Imagion Biosystems, Ltd., registered at Bourke Street, Melbourne, with a US subsidiary, Imagion Biosystems, Inc., in Incline Village, Nevada, develops MagSense molecular MRI: bio-safe magnetic nanoparticles linked to targeting molecules that bind cancer biomarkers. Its lead agent, the MagSense HER2 Imaging Agent (MSH2IA), completed a multi-site phase 1 study (enrolment closed in July 2023) in HER2-positive breast cancer to assess spread to axillary lymph nodes, and the company says it detects tumour signals as small as 1 to 2 mm; a folate receptor agent for ovarian cancer is preclinical. The company identifies itself as IBX and publishes ASX announcements. Its first registered cancer trial on ClinicalTrials.gov, NCT07885683, a phase 1b/2 study of MSH2IA with MRI in HER2-positive breast cancer, was posted in October 2026; no earlier study is registered on ClinicalTrials.gov under this sponsor name.
Notes
- The ticker IBX and an ASX listing are inferred from the company's investor site, which lists 'ASX Announcements' and refers to the company as IBX; an exchange-and-ticker statement was not found in the text read. Founding year not stated. The 1 to 2 mm detection claim is the company's own. Read on 29 October 2026.
Connected
5Similar pages
- IdeaBrain metastases included by default in every solid-tumour trial
Shares MRI, HER2-positive breast cancer.
- IdeaRead the spinal fluid to track brain tumours without opening the skull
Shares MRI, HER2-positive breast cancer.
- TrialI-SPY 1 (CALGB 150007/150012, ACRIN 6657)
Shares MRI, HER2-positive breast cancer.
- TrialI-SPY 2.2
Shares MRI, HER2-positive breast cancer.
- CancerPaget disease of the nipple
Shares MRI, HER2-positive breast cancer.
- IdeaPrevention trials aimed only at brain metastasis
Shares MRI, HER2-positive breast cancer.
- TermHER2-positive brain metastases
Shares MRI, HER2-positive breast cancer.
- CancerLocalised small bowel adenocarcinoma (stage I to III, resected)
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
imagionbiosystems.com · 2
ClinicalTrials.gov · 1
A source that has moved or gone is reported by the weekly link check. /audit/